Long noncoding RNA loss in immune suppression in cancer

Qingsong Hu, Sergey D. Egranov, Chunru Lin, Liuqing Yang

Research output: Contribution to journalReview articlepeer-review

37 Scopus citations

Abstract

Long noncoding RNAs (lncRNAs) have multiple functions in the regulation of cellular homeostasis. In recent years, numerous studies have shown that tumor-associated lncRNAs play key roles in promoting and maintaining tumor initiation and progression by shaping the tumor microenvironment through changing tumor cell intrinsic properties. Here, we focus on the roles of lncRNAs in cancer immunology. In the first part, we provide an overview of the roles played by lncRNAs and their deregulation in cancer at the cancer cell- and tumor microenvironment-associated immune cell levels. We go on to describe preclinical strategies for targeting lncRNAs, particularly highlighting the effects on tumor microenvironments. We then discuss the possibility of combining lncRNA targeting and tumor immune checkpoint inhibitor antibodies to treat cancer.

Original languageEnglish (US)
Article number107591
JournalPharmacology and Therapeutics
Volume213
DOIs
StatePublished - Sep 2020

Keywords

  • Cancer immunotherapy
  • Long noncoding RNA
  • Tumor-cell-extrinsic factors
  • Tumor-cell-intrinsic factors

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Long noncoding RNA loss in immune suppression in cancer'. Together they form a unique fingerprint.

Cite this